JANSSEN-CILAG PTY LTD

🇳🇿New Zealand

Country: 🇳🇿New Zealand

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Paliperidone Palmitate Effectiveness Assessment Registry - Longitudinal (PEARL)

Completed

Conditions: Schizophrenia

Interventions: Drug: paliperidone palmitate

First Posted Date: 2011-05-30

Last Posted Date: 2016-03-10

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 127

Registration Number: NCT01362426

Long Term Follow-Up Study of Human Immunodeficiency Virus Type 1 (HIV-1) Positive Patients Who Have Received OZ1 Gene Therapy as Part of a Clinical Trial

Phase 2

Completed

Conditions: HIV-1

Interventions: Genetic: OZ1 transduced cells

First Posted Date: 2010-08-06

Last Posted Date: 2018-12-12

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 68

Registration Number: NCT01177059

Schizophrenia Treatment Adherence Investigation (STAI)

Completed

Conditions: Schizoaffective Disorder
Schizophrenia

Interventions: Other: Risk status for medication adherence

First Posted Date: 2009-10-26

Last Posted Date: 2014-04-09

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 550

Registration Number: NCT01001481

A Study of Efficacy of Treatment With Bortezomib (in Combination With Doxorubicin and Dexamethasone) in Previously Untreated Patients With Multiple Myeloma

Phase 2

Completed

Conditions: Multiple Myeloma

Interventions: Drug: PAD induction

First Posted Date: 2009-03-31

Last Posted Date: 2014-05-16

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 107

Registration Number: NCT00872521

A Pilot Trial to Evaluate the Effect of Diet and Exercise in Renal Transplant Recipients on Tacrolimus

Phase 4

Completed

Conditions: Kidney Transplantion
Renal Transplantion

Interventions: Drug: Tacrolimus With Diet and Exercise Intervention

First Posted Date: 2007-06-27

Last Posted Date: 2013-05-27

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 55

Registration Number: NCT00492661

An Open Label Multicentre Study to Determine the Dose Distribution of Paliperidone ER in Patients With Schizophrenia

Phase 3

Completed

Conditions: Schizophrenia

Interventions: Drug: Paliperidone

First Posted Date: 2007-05-15

Last Posted Date: 2012-12-05

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 64

Registration Number: NCT00473434

A Study to Compare the Number of Patients With Gastro-Oesophageal Reflux Disease (GORD) Achieving Heartburn and Regurgitation Symptom Resolution After Treatment With Either Rabeprazole Sodium 20mg, Esomeprazole 20mg or Esomeprazole 40mg

Phase 4

Completed

Conditions: Gastro-oesophageal Reflux

Interventions: Drug: Rabeprazole
Drug: Esomeprazole

First Posted Date: 2007-04-23

Last Posted Date: 2014-04-21

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 1392

Registration Number: NCT00464308

An Observational Study of the Safety and Effectiveness of Galantamine in the Treatment of Patients With Alzheimer's Disease Over an 18-month Period

Completed

Conditions: Alzheimer Disease
Galantamine
Dementia

Interventions: Drug: Galantamine (Reminyl)

First Posted Date: 2006-03-07

Last Posted Date: 2014-05-23

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 61

Registration Number: NCT00299676

Prospective Research in Memory Clinics (PRIME)

Completed

Conditions: Dementia
Mild Cognitive Impairment

Interventions: Other: Current treatment practice of each participating physician

First Posted Date: 2006-02-28

Last Posted Date: 2013-12-02

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 970

Registration Number: NCT00297271

Pre-transplant Assessment of Tacrolimus Blood Level Concentration, as a Predictor of Tacrolimus Dose Requirements After Kidney Transplantation

Phase 4

Completed

Conditions: Kidney Transplantation
Transplantation

First Posted Date: 2006-02-28

Last Posted Date: 2011-06-20

Lead Sponsor: Janssen-Cilag Pty Ltd

Target Recruit Count: 89

Registration Number: NCT00297310

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy